Hyperemesis Gravidarum
30
2
2
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
2 terminated out of 30 trials
90.5%
+4.0% vs benchmark
13%
4 trials in Phase 3/4
21%
4 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (30)
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
Hyperemesis Gravidarum Risk Reduction With Metformin
Tablet Ginger Versus Tablet Doxylamine Succinate in Control of Nausea and Vomiting in Pregnancy
Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)
Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum
Chewing Gum Containing Vitamin-c to Treat Emesis Gravidarum
Effects Of Emotional Freedom Technique and Hypermesis Gravidarum
The Effect of Mint Flavored Chewing Gum on Hyperemesis Gravidarum Nausea Vomiting Severity, Coping With Stress and Anxiety Level in Pregnants With Hyperemesis Gravidarum
Inflammation Markers in Hyperemesis Gravidarum
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
MinSafeStart - Decision Aid Tool for Better Treatment of Nausea and Vomiting During Pregnancy
Use of Hypnosis in Hyperemesis Gravidarum
The Effect of Guided Imagery and Diaphragmatic Breathing Exercise in Pregnant Women With Hyperemesis Gravidarum
Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment
Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum
The Levels of the Orexin, Galanin and aMSH and CART in Patients With Hyperemesis Gravidarum
Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
Acupressure in Hyperemesis Gravidarum
Gallbladder Functions & Serum Cholecystokinin Levels in Women Diagnosed With Hyperemesis Gravidarum
Hyperemesis Gravidarum and Osteoporosis